NHMRX
Price
$14.38
Change
-$0.02 (-0.14%)
Updated
Jun 10 closing price
Net Assets
12.68B
PTYIX
Price
$11.21
Change
-$0.02 (-0.18%)
Updated
Jun 10 closing price
Net Assets
3.63B
Interact to see
Advertisement

NHMRX vs PTYIX

Header iconNHMRX vs PTYIX Comparison
Open Charts NHMRX vs PTYIXBanner chart's image
NHMRX vs PTYIX Comparison Chart in %
View a ticker or compare two or three
VS
NHMRX vs. PTYIX commentary
Jun 11, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NHMRX is a Hold and PTYIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
NHMRX has more cash in the bank: 12.7B vs. PTYIX (3.64B). NHMRX pays higher dividends than PTYIX: NHMRX (5.63) vs PTYIX (4.20). NHMRX was incepted earlier than PTYIX: NHMRX (27 years) vs PTYIX (10 years). NHMRX (1.80) is less costly to investors than PTYIX (0.50). NHMRX is a more actively managed with annual turnover of: 18.00 vs. PTYIX (14.20). NHMRX has a lower initial minimum investment than PTYIX: NHMRX (100000) vs PTYIX (500000). NHMRX (9.46) and PTYIX (9.45) have marching annual gain over last year. PTYIX return over 5 years is better than : 7.23 vs. NHMRX (1.88).
NHMRXPTYIXNHMRX / PTYIX
Total Expense Ratio1.800.50360%
Annual Report Gross Expense Ratio1.800.50360%
Fund Existence27 years10 years-
Gain YTD3.1103.046102%
Front LoadN/AN/A-
Min. Initial Investment10000050000020%
Min. Initial Investment IRAN/AN/A-
Net Assets12.7B3.64B349%
Annual Yield % from dividends5.634.20134%
Returns for 1 year9.469.45100%
Returns for 3 years12.6318.2769%
Returns for 5 years1.887.2326%
Returns for 10 years26.40N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PIEIX40.42N/A
N/A
Principal Glb Emerging Markets Inst
SUHAX37.16N/A
N/A
DWS Health and Wellness A
HAORX19.04N/A
N/A
Harbor International Core Retirement
HGHVX49.14N/A
N/A
Hartford Healthcare R6
MDOAX11.66N/A
N/A
Morgan Stanley Developing Opportunity A